Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
22%
OVERLAP
BY WEIGHT
42
# OF OVERLAPPING
HOLDINGS
VHT
421
HOLDINGS
11%
ALSO IN CANC
CANC
56
HOLDINGS
75%
ALSO IN VHT
SECTOR DRIFT (VHT minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.8% | 4.5% | 4.5% |
|
MERCK & CO. INC. | 4.6% | 3.9% | 3.9% |
|
JOHNSON & JOHNSON | 5.4% | 2.5% | 2.5% |
|
AMGEN INC | 3.1% | 2.5% | 2.5% |
|
ABBVIE INC | 5.0% | 2.4% | 2.4% |
VHT Overweight Relative to CANC
|
ELI LILLY & CO | 8.3% |
|
UNITEDHEALTH GROUP INC | 3.6% |
|
THERMO FISHER SCIENTIFIC INC | 3.1% |
|
ABBOTT LABORATORIES | 2.9% |
|
JOHNSON & JOHNSON | 2.9% |
|
INTUITIVE SURGICAL INC | 2.6% |
|
ABBVIE INC | 2.6% |
|
PFIZER INC | 2.3% |
|
DANAHER CORP | 2.1% |
 |
MEDTRONIC PLC | 2.0% |
VHT Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -6.0% |
 |
NOVARTIS AG | -4.6% |
|
BRIDGEBIO PHARMA, INC. | -4.4% |
 |
ASTRAZENECA PLC | -4.4% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.1% |
 |
GENMAB A/S SPONSORED ADR | -3.4% |
|
NUVALENT, INC. CLASS A | -3.2% |
|
COGENT BIOSCIENCES INC | -3.2% |
|
IMMUNOME, INC. | -2.9% |
|
BRISTOL-MYERS SQUIBB CO | -2.4% |